News - Anti-Arthritics/Rheumatics, Krystexxa


Popular Filters

Majority of gout patients on uric acid lowering therapy fail to achieve control of serum urate levels report


While rheumatologists and primary care physicians (PCPs) in the USA recognize the importance of tight…

allopurinolAnti-Arthritics/RheumaticsKrystexxaMarkets & MarketingNorth AmericaPharmaceuticalUloric

Allopurinol remains gout market leader but Uloric making inroads, study finds


Most surveyed rheumatologists, nephrologists and primary care physicians cite increased use of Takeda's…

allopurinolAnti-Arthritics/RheumaticsGenito-urinaryKrystexxaMarkets & MarketingPharmaceuticalSavient PharmaceuticalsTakeda PharmaceuticalsUloric

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top